Michael F Concino

This inventor holds 27 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 12 EPO patents, primarily in Lysosomal Enzyme Targeting. Top assignees: Shire Human Genetic Therapies, Inc., Johns Hopkins University, The Brigham and Women's Hospital, Inc.. Active years: 1993-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael F Concino. Retrieved from https://idiyas.com/inventor/michael-f-concino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 7)

% Patents Active = 92.6

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 12 (Patent Applications = 14)

Average Co-Inventor Count = 4.2

ph-index = 9

Forward Citations = 381(Granted Patents)

Location History:

Newton, MA (US) (1993 - 2005)
Lexington, MA (US) (2020)
Bolton, MA (US) (2007 - 2021)

Company Filing History:

15 out of 86

Shire Human Genetic Therapies, Inc.

patents

5 out of 3,798

Johns Hopkins University

patents

5 out of 1,425

The Brigham and Women's Hospital, Inc.

patents

4. 4 out of 24

T Cell Sciences, Inc.

patents

5. 4 out of 40

Transkaryotic Therapies, Inc.

patents

6. 2 out of 20

Avant Immunotherapeutics, Inc.

Synageva Biopharma Corporation

patents

where one patent can have more than one assignee

Years Active: 1993-2021

Loading Chart...

Areas of Expertise:

Lysosomal Targeting

Alpha-N-Acetylglucosaminidase

Mitochondrial Targeting

Chimeric Proteins

Peptide Linkers

Recombinant Proteins

Duchenne Muscular Dystrophy

Sanfilippo Syndrome

Human C3b/C4b Receptor

Hypertriglyceridemia

Lysosomal Acid Lipase Deficiency

Nucleic Acids

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11065307 - Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety (2021-07-20),

2. 10729746 - Recombinant placenta growth factor for treating Duchenne muscular dystrophy (2020-08-04),

3. 10722559 - Mannose-6-phosphate bearing peptides fused to lysosomal enzymes (2020-07-28),

4. 10603364 - Lysosomal targeting and uses thereof (2020-03-31),

5. 10556015 - Lysosomal targeting of enzymes, and uses thereof (2020-02-11),

6. 9932568 - Peptide linkers for polypeptide compositions and methods for using same (2018-04-03),

7. 9932377 - Mitochondrial targeting and therapeutic use thereof (2018-04-03),

8. 9814764 - Treatment of Sanfilippo syndrome type B by intrathecal administration of alpha-n-acetylglucosaminidase (2017-11-14),

9. 9708590 - Crystal structure of human α-N-acetylglucosaminidase (2017-07-18),

10. 9597376 - Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitis (2017-03-21),

11. 9453847 - Mannose receptor C type 1 (MRC1) codon optimized cell line and uses thereof (2016-09-27),

12. 9260495 - Mitochondrial targeting and therapeutic use thereof (2016-02-16),

13. 9206235 - Peptide linkers for polypeptide compositions and methods for using same (2015-12-08),

14. 8945542 - Methods for treating lysosomal acid lipase deficiency (2015-02-03),

15. 8775146 - Crystal structure of human alpha-N-acetylglucosaminidase (2014-07-08),

Title: The Innovative Journey of Michael F Concino

Introduction: Michael F Concino, a talented inventor hailing from Bolton, MA (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Michael F Concino holds several patents in various technological domains, including advancements in renewable energy systems, artificial intelligence algorithms, and medical devices.

Career Highlights: With a career spanning over two decades, Michael F Concino has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Throughout his career, Michael F Concino has collaborated with top engineers, scientists, and researchers to bring his innovative ideas to life. His collaborative efforts have resulted in the successful commercialization of several patented inventions.

Conclusion: Michael F Concino's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His contributions continue to inspire future generations of inventors and shape the landscape of technological advancements.

Profile summary based on public USPTO records.